Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease.

Igor Novitzky-Basso,Frida Schain,Nurgul Batyrbekova,Thomas Webb,Mats Remberger,Armand Keating,Jonas Mattsson

PloS one（2023）

引用 0|浏览8

暂无评分

摘要

cGVHD incidence was high among HSCT survivors. Non-cGVHD patients had higher mortality during the first 6 months of follow-up; however, moderate-severe cGVHD patients had more comorbidities and healthcare utilization. This study highlights the urgent need for new treatments and real-time methods to monitor effective immunosuppression after HSCT.

查看译文

关键词

clinical outcomes,population-based,real-world,graft-versus-host

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要